Shukla Sath

CEO & PresidentSpero Therapeutics, Inc. (SPRO) · full profile →Form 4 · filed Feb 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$121K
Net Open-Market Flow
-$121K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2025Sell(S)106K$0.78$83K1.7M
Feb 5, 2025Sell(S)43K$0.78$33K1.8M
Feb 5, 2025Sell(S)6K$0.78$5K1.9M
Feb 3, 2025Grant(A)751K$01.9M

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-014850) within minutes of acceptance. Every field above traces to the original document. Verify it directly: